Characteristics of intracerebral hematomas associated with anticoagulant therapy
Abstract
This study was provided to characterize the localization of intracerebral hematomas, associated with anticoagulant therapy, in patients with warfarin-associated and spontaneous hypertensive intracerebral hematomas. It is found that warfarin-associated hematoma is characterized by a common site in the cerebellum compared with hypertensive intracerebral hematomas.
About the Authors
S. A. Chugunova
North-Eastern Federal university named after M.K. Ammosov
Russian Federation
Russian Federation
Chugunova Sargylana A. – PhD, docent of Department of Neurology and Psychiatry
Yakutsk
93 A, Petr Alekseev street, Yakutsk, 677005
Phone/fax: +7(4112) 43-27-40
T. Ya. Nikolayeva
North-Eastern Federal University named after M.K. Ammosov
Russian Federation
Russian Federation
Nikolayeva Tatiana Ya. – MD, professor, Head of Department of Neurology and Psychiatry
36, Kulakovsky street, Yakutsk, 677007
Phone/fax: +7(4112) 49-67-00
T. S. Egorova
North-Eastern Federal University named after M.K. Ammosov
Russian Federation
Russian Federation
Egorova Tuyara S. - neurologist, ordinator of Department of internal medicine and general practice (family medicine)
36, Kulakovsky street, Yakutsk, 677007, Phone/fax: +7(4112) 49-67-00
References
1. The gene polymorphism of CYP2C9 and VKORC1, affect the sensitivity to anticoagulant therapy in patients with acute ischemic stroke / S.A.Chugunova, T.Ya.Nikolaeva, A.L. Danilova [et al.] // Yakut Medical Journal. - V. 2 (46). - 2014. - P. 64 - 67.
2. Skvortsova V.I. A hemorrhagic stroke: practical guide / V.I.Skvortsova, V.V.Krylov; ed. V. I. Skvortsova, V.V.Krylov. – M.: «GEOTARMedia», 2005. - 155 p.
3. Toole J.F. Cerebrovascular disease: practical guide; trans. from English. / J. F. Toole; ed. E.I.Gusev, A.B. Hecht. 6th ed. – M.: «GEOTARMedia», 2007. - 608 p.
4. Age and the Risk of Warfarin Associated Hemorrhage: The Anticoagulation and Risk Factors in Atrial Fibrillation Study / M. C. Fang, A.S. Go, E.M. Hylek [et al.] // J Am Geriatr Soc. - 2006. - V. 54 (8). - P.1231-1236. /// Doi: 10.1111/j.15325415.2006.00828.
5. Antithrombotic therapy and predilection for cerebellar hemorrhage / K. Toyoda, Y. Okada, S. Ibayashi [et al.] // Cerebrovasc Dis. - 2007. - V. 23 (2-3). - P. 109 - 116.
6. Apixaban versus warfarin in patients with atrial fibrillation / C.B. Granger, J.H Alexander, J.J. McMurray [et al.] // N Engl J Med. - 2011. - V.365. - P.981 - 992.
7. Bleeding complications of oral anticoagulant treatment: An inception cohort, prospective collaborative study (ISCOAT) / G. Palareti, N. Leali, S. Coccheri [et al.] // Lancet. - 1996. - V. 348. - P.423 - 428.
8. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials / C.T. Ruff, R.P. Giugliano, E. Braunwald [et al]. // Lancet. - 2014. - V. 383. - P. 955 - 962.
9. Dabigatran versus warfarin in patients with atrial fibrillation / S. J. Connolly, M. D. Ezekowitz, S.Yusuf [et al.] // N Engl J Med. - 2009. - V. 361. - P.1139 - 1151.
10. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes / D. M. Witt, T. Delatea, E. M. Hylekc [et al.] // Thrombosis Research. - 2013. - V.132. - P. 770 - 775.
11. Flaherty M.L. Anticoagulant-associated intracerebral hemorrhage / M.L. Flaherty // Semin Neurol. – 2010. - V. 30 (5). - P. 565- 572. /// doi: 10.1055/s-0030-1268866.
12. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage / J.C. Hemphill, S. M. Greenberg, C.S. Anderson [et al.] // Stroke. - 2015. - V. 46. - P. 2032 - 2060.
13. Hart R.G. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas [Text] / R.G. Hart, S.B. Tonarelli, L.A. Pearce // Stroke. - 2005. - V. 36 (7). - P. 1588 -1593.
14. Hart R.G. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation / R.G. Hart, L.A. Pearce, M.I. Aguilar // Ann. Intern Med. - 2007. - V.146 (12). - P.857 - 867.
15. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial / R.G. Hart, H.C. Diener, S. Yang [et al.] // Stroke. - 2012. - V. 43 (6). - P. 1511-1517. /// Doi: 10.1161/STROKEAHA.112.650614.
16. Landefeld C.S. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy / C.S. Landefeld, L. Goldman // Am J Med. - 1989. - V.87. - P.144 - 152.
17. Location of acute brain hemorrhage in patients undergoing antithrombotic therapy / R. Itabashi, M. Yasaka, T. Kuwashiro [et al.] // J Neurol Sci. - 2009. - V. 280 (1-2). - P. 87 - 89. /// doi: 10.1016/j.jns.2009.02.304.
18. Meschia J.F. Advances in genetics in 2010 / J.F. Meschia // Stroke. - 2011. - V.42. - P. 285 - 287.
19. Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry / S.D. Pokorney, D.N. Simon, L. Thomas [et al.] // Am Heart J. - 2015. - V. 170 (1). - P.141- 148. // doi: 10.1016/j.ahj.2015.03.017
20. Qureshi A. I. Spontaneous intracerebral hemorrhage [Text] / A. I. Qureshi, S. Tuhrim S, J. P. Broderick [et al.] // New England Journal of Medicine. - 2001. - Vol. 344. - P. 1450 - 1460.
21. Risk factors for intracerebral hemorrhage differ according to hemorrhage location / S.R. Martini, M.L. Flaherty, W.M. Brown [et al.] // Neurology. - 2012. - V.79 (23). - P. 2275 - 2282. /// doi: 10.1212/WNL.0b013e318276896f
22. Steiner T. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions / T. Steiner, J. Rosand, M. Diringer // Stroke. - 2006. - V. 37 (1). - P.256 - 262.
23. Stroke: Pathophysiology, Diagnosis and Management / Ed. H. J. M. Barnett, J. P. Mohr, B. M. Stein, F. M. Yatsu. Second Edition. - New York, «Churchill Livingstone»: 1992. - 1270 p.
24. The Harvard Cooperative Stroke Registry: a prospective registry [Text] / J. P. Mohr [et al.] L. R. Caplan, J. W. Melski [et al.] // Neurology. - 1978. - Vol. 28. - P. 754.
25. The increasing incidence of anticoagulantassociated intracerebral hemorrhage [Text] / M.L. Flaherty, B. Kissela, D. Woo [et al.] // Neurology. - 2007. - V. 68 (2). - P. 116-121.
26. The risk for and severity of bleeding complications in elderly patients treated with warfarin [Text] / S.D. Fihn, C.M. Callahan, D.C. Martin [et al.] // Ann Intern Med. - 1996. -V.124. - P. 970 - 979.
27. Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location [Text] / M. Ma, A. Meretoja, L. Churilov [et al] // J Neurol Sci. - 2013. - V. 332 (1-2). - P.75 - 79. /// doi: 10.1016/j.jns.2013.06.020.
Review
For citations:
Chugunova S.A., Nikolayeva T.Ya., Egorova T.S. Characteristics of intracerebral hematomas associated with anticoagulant therapy. Yakut Medical Journal. 2016;(2):63-66.
Views:
38
Email this article 